Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8739662 | Journal of Clinical Virology | 2018 | 25 Pages |
Abstract
An Abbott ARCHITECT® HBsAg assay with clinical performance approaching that of mini-pool NAT (approximately 100 copies/ml was developed. The assay has superior HBsAg mutant and genotype detection and specificity, all of which are important for the diagnosis and management of HBV infection.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sheng Lou, Russell Taylor, Sandra Pearce, Mary Kuhns, Thomas Leary,